about
HIV-associated neuropathogenesis: a systems biology perspective for modeling and therapyThe retromer complex is required for rhodopsin recycling and its loss leads to photoreceptor degenerationA paired RNAi and RabGAP overexpression screen identifies Rab11 as a regulator of β-amyloid production.Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects.Retromer: a master conductor of endosome sorting.Hyperleucinemia causes hippocampal retromer deficiency linking diabetes to Alzheimer's disease.Overexpression of the Insulin-Like Growth Factor II Receptor Increases β-Amyloid Production and Affects Cell Viability.Increased expression of reticulon 3 in neurons leads to reduced axonal transport of β site amyloid precursor protein-cleaving enzyme 1.Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease.Membrane trafficking pathways in Alzheimer's disease.The Role of Retromer in Alzheimer's Disease.Sorting receptors at Down's syndrome synapses.Identification of novel transplantable GPCR recycling motif for drug discovery.GGA1 regulates signal-dependent sorting of BACE1 to recycling endosomes, which moderates Aβ production.Analysis of novel endosome-to-Golgi retrieval genes reveals a role for PLD3 in regulating endosomal protein sorting and amyloid precursor protein processing.Amyloid precursor protein traffics from the Golgi directly to early endosomes in an Arl5b- and AP4-dependent pathway.Retrograde trafficking from the endosome to the trans-Golgi network mediated by the retromer is required for fungal development and pathogenicity in Fusarium graminearum.
P2860
Q26859071-5AADF4AA-A46C-46E6-8DF8-7B005AB4D8C3Q27315072-4E27F66D-248F-48E8-BB4B-0D2580D381EFQ30577278-CFC4B021-003B-4360-ACE2-C0EEFA56E0F0Q33862796-20D1F367-B92E-42BF-A3F6-174473DB7043Q34401990-FAC43447-77E2-47A0-BA27-EF12C5A7B15CQ34531278-3E30218E-55C4-4611-9174-0456DD9AB43FQ35764183-EFCA3A1D-24E8-4FA2-A658-BADFDE6C2919Q37234006-74EE4799-278F-424E-AC34-428524108C4CQ37559812-378E46E3-1526-4001-98D1-929D56372AE9Q37978006-8E0C4E49-0BD3-4B27-A5E4-C9BAC2516AECQ38555413-3F9F0F90-F827-4E3B-B893-1B179E12CE83Q44492886-6FF12744-B372-438D-BB5E-693BA221A7E6Q46415166-1EB00B25-5ABA-4FDE-B0E3-BA7E47C739FDQ47398628-9CE1C5DE-6D0D-42E1-AB58-A5A9377D6314Q48170739-7C549D83-91BD-4042-8AC4-326AA2F859C2Q51246028-513DF31C-C53F-4B7D-A31E-FC574E36859EQ52668353-D6B9C163-C7A5-46CE-9957-BA71EE32980D
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Retromers in Alzheimer's disease.
@en
Retromers in Alzheimer's disease.
@nl
type
label
Retromers in Alzheimer's disease.
@en
Retromers in Alzheimer's disease.
@nl
prefLabel
Retromers in Alzheimer's disease.
@en
Retromers in Alzheimer's disease.
@nl
P2860
P356
P1476
Retromers in Alzheimer's disease.
@en
P2093
Barbara M Siegenthaler
P2860
P304
P356
10.1159/000335910
P577
2012-03-03T00:00:00Z